tradingkey.logo

SWK Holdings Corp

SWKH
16.660USD
+2.260+15.69%
Close 10/10, 16:00ETQuotes delayed by 15 min
202.98MMarket Cap
11.66P/E TTM

SWK Holdings Corp

16.660
+2.260+15.69%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of SWK Holdings Corp

Currency: USD Updated: 2025-10-10

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

SWK Holdings Corp's Score

Industry at a Glance

Industry Ranking
26 / 398
Overall Ranking
81 / 4697
Industry
Banking Services

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 1 analysts
Buy
Current Rating
18.500
Target Price
+11.04%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

SWK Holdings Corp Highlights

StrengthsRisks
SWK Holdings Corporation is engaged in specialty finance and asset management business. The Company’s segments include Finance Receivables and Pharmaceutical Development. Finance Receivables segment is a healthcare capital provider, which offers customized financing solutions to a range of life science companies, institutions, and inventors. This segment is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Its Pharmaceutical Development segment operates through its subsidiary Enteris BioPharma, Inc. (Enteris). Enteris is a clinical development and manufacturing organization providing development services to pharmaceutical partners as well as innovative formulation solutions built around its oral drug delivery technologies, the Peptelligence platform.
Growing
The company is in a growing phase, with the latest annual income totaling USD 44.99M.
Overvalued
The company’s latest PB is 0.82, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 10.61M shares, decreasing 2.30% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 37.20K shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-10

The company's current financial score is 8.02, which is higher than the Banking Services industry's average of 7.04. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 10.05M, representing a year-over-year decrease of 12.90%, while its net profit experienced a year-over-year decrease of 19.54%.

Score

Industry at a Glance

Previous score
8.02
Change
0

Financials

8.93

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
No Data

Quality of Earnings

9.67

Operational Efficiency

8.34

Growth Potential

5.89

Shareholder Returns

7.24

SWK Holdings Corp's Company Valuation

Currency: USD Updated: 2025-10-10

The company’s current valuation score is 8.21, which is higher than the Banking Services industry's average of 7.68. Its current P/E ratio is 11.74, which is 38.44% below the recent high of 16.26 and 25.86% above the recent low of 8.71.

Score

Industry at a Glance

Previous score
8.21
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 26/398
No Data

Earnings Forecast

Currency: USD Updated: 2025-10-10

The company’s current earnings forecast score is 8.00, which is higher than the Banking Services industry's average of 7.40. The average price target for SWK Holdings Corp is 18.50, with a high of 18.50 and a low of 18.50.

Score

Industry at a Glance

Previous score
8.00
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 1 analysts
Buy
Current Rating
18.500
Target Price
+11.04%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

15
Total
4
Median
4
Average
Company name
Ratings
Analysts
SWK Holdings Corp
SWKH
1
Runway Growth Finance Corp
RWAY
11
AerCap Holdings NV
AER
9
NewtekOne Inc
NEWT
7
MSC Income Fund Inc
MSIF
6
Jefferson Capital Inc
JCAP
5
1
2
3

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-10

The company’s current price momentum score is 9.14, which is higher than the Banking Services industry's average of 6.62. Sideways: Currently, the stock price is trading between the resistance level at 18.31 and the support level at 14.61, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.59
Change
2.55

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(0)
Buy(5)
Indicators
Value
Direction
MACD(12,26,9)
0.247
Buy
RSI(14)
77.521
Buy
STOCH(KDJ)(9,3,3)
42.027
Buy
ATR(14)
0.523
High Vlolatility
CCI(14)
435.103
Overbought
Williams %R
33.667
Buy
TRIX(12,20)
0.027
Sell
StochRSI(14)
100.000
Buy
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
14.872
Buy
MA10
14.775
Buy
MA20
14.663
Buy
MA50
14.635
Buy
MA100
14.677
Buy
MA200
14.038
Buy

Institutional Confidence

Currency: USD Updated: 2025-10-10

The company’s current institutional recognition score is 7.00, which is higher than the Banking Services industry's average of 5.34. The latest institutional shareholding proportion is 87.38%, representing a quarter-over-quarter decrease of 7.21%. The largest institutional shareholder is The Vanguard, holding a total of 201.06K shares, representing 1.66% of shares outstanding, with 13.72% decrease in holdings.

Score

Industry at a Glance

Previous score
7.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
Carlson Capital, L.P.
8.49M
--
M3F, Inc.
698.43K
-11.78%
Carlson (Clint Duane)
399.39K
--
Cannell Capital, LLC
314.62K
-11.31%
The Vanguard Group, Inc.
Star Investors
201.06K
-13.78%
BlackRock Institutional Trust Company, N.A.
125.82K
+11.92%
Staggs (Joe David JR)
116.73K
+0.74%
Bridgeway Capital Management, LLC
114.28K
+2.94%
Geode Capital Management, L.L.C.
75.32K
-1.26%
Raymond James Financial Services Advisors, Inc.
74.66K
+297.47%
1
2

Risk Assessment

Currency: USD Updated: 2025-10-10

The company’s current risk assessment score is 4.94, which is lower than the Banking Services industry's average of 6.61. The company's beta value is 0.21. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
4.94
Change
0
Beta vs S&P 500 index
0.21
VaR
+2.42%
240-Day Maximum Drawdown
+12.75%
240-Day Volatility
+37.96%

Return

Best Daily Return
60 days
+15.69%
120 days
+22.59%
5 years
+22.59%
Worst Daily Return
60 days
-3.50%
120 days
-5.75%
5 years
-6.81%
Sharpe Ratio
60 days
+1.25
120 days
+1.98
5 years
+0.58

Risk Assessment

Maximum Drawdown
240 days
+12.75%
3 years
+23.51%
5 years
+23.97%
Return-to-Drawdown Ratio
240 days
+2.05
3 years
+0.14
5 years
+0.36
Skewness
240 days
+4.89
3 years
+3.74
5 years
+2.38

Volatility

Realised Volatility
240 days
+37.96%
5 years
+35.25%
Standardised True Range
240 days
+2.15%
5 years
+2.16%
Downside Risk-Adjusted Return
120 days
+545.92%
240 days
+545.92%
Maximum Daily Upside Volatility
60 days
+51.37%
Maximum Daily Downside Volatility
60 days
+31.96%

Liquidity

Average Turnover Rate
60 days
+0.12%
120 days
+0.15%
5 years
--
Turnover Deviation
20 days
+20.16%
60 days
+26.74%
120 days
+60.38%

Peer Comparison

Banking Services
SWK Holdings Corp
SWK Holdings Corp
SWKH
7.86 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
East West Bancorp Inc
East West Bancorp Inc
EWBC
8.46 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
AerCap Holdings NV
AerCap Holdings NV
AER
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Wintrust Financial Corp
Wintrust Financial Corp
WTFC
8.40 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bank Ozk
Bank Ozk
OZK
8.36 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
UMB Financial Corp
UMB Financial Corp
UMBF
8.33 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI